114 related articles for article (PubMed ID: 8276300)
41. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
42. Radioactive phosphorus and external radiation as an adjuvant to surgery for ovarian carcinoma.
Julian CG; Inalsingh CH; Burnett LS
Obstet Gynecol; 1978 Aug; 52(2):155-60. PubMed ID: 683654
[TBL] [Abstract][Full Text] [Related]
43. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities.
Kaern J; Tropé CG; Abeler VM
Cancer; 1993 Mar; 71(5):1810-20. PubMed ID: 8383580
[TBL] [Abstract][Full Text] [Related]
44. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment.
Manchul LA; Simm J; Levin W; Fyles AW; Dembo AJ; Pringle JF; Rawlings GA; Sturgeon JF; Thomas GM
Int J Radiat Oncol Biol Phys; 1992; 22(5):867-74. PubMed ID: 1555978
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of serous adenocarcinoma of the ovary by a protocol consisting of 1st surgery, polychemotherapy with cisplatin as base, surgical reoperation for control, and radiotherapy and/or maintenance chemotherapy. Study of a series of 56 cases. Thoughts and prospects].
Clavel B; Delouche G; Harvey P; Berlie J; Laval C; Tubiana-Hulin M; Lemoine F
Ann Chir; 1984 Jun; 38(5):337-47. PubMed ID: 6541016
[No Abstract] [Full Text] [Related]
46. A randomised study of cisplatin versus thiotepa as induction chemotherapy in advanced ovarian carcinoma.
Dørum A; Kristensen GB; Tropé C
Eur J Cancer; 1994; 30A(10):1470-4. PubMed ID: 7833104
[TBL] [Abstract][Full Text] [Related]
47. Radioisotopes in the treatment of ovarian cancer.
Rosenshein NB
Clin Obstet Gynaecol; 1983 Aug; 10(2):279-95. PubMed ID: 6617040
[TBL] [Abstract][Full Text] [Related]
48. Thio-tepa chemotherapy for ovarian carcinoma. Influence of remission and toxicity on survival.
Wallach RC; Kabakow B; Blinick G; Antopol W
Obstet Gynecol; 1970 Feb; 35(2):278-86. PubMed ID: 4189962
[No Abstract] [Full Text] [Related]
49. [Adjuvant thio-tepa in the treatment of bladder papilloma. A prospective randomized study].
Malling N; Sørensen SS
Ugeskr Laeger; 1980 Jun; 142(26):1678-9. PubMed ID: 6773198
[No Abstract] [Full Text] [Related]
50. Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Analysis of 313 patients treated primarily or at second-look laparotomy.
Vergote IB; Winderen M; De Vos LN; Tropé CG
Cancer; 1993 Apr; 71(7):2250-60. PubMed ID: 8453546
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Soper JT; Berchuck A; Clarke-Pearson DL
Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
[TBL] [Abstract][Full Text] [Related]
52. [Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans].
Neĭshtadt EL; Gnilevskaia ZU; Aĭnbinder NM
Vopr Onkol; 1975; 21(7):48-53. PubMed ID: 814712
[TBL] [Abstract][Full Text] [Related]
53. Postoperative irradiation and chemotherapy in patients with advanced ovarian cancer.
Welander C; Kjørstad KE; Kolstad P
Acta Obstet Gynecol Scand; 1978; 57(2):161-4. PubMed ID: 416647
[TBL] [Abstract][Full Text] [Related]
54. The West Midlands epithelial ovarian cancer adjuvant therapy trial.
Redman CW; Mould J; Warwick J; Rollason T; Luesley DM; Budden J; Lawton FG; Blackledge GR; Chan KK
Clin Oncol (R Coll Radiol); 1993; 5(1):1-5. PubMed ID: 8424908
[TBL] [Abstract][Full Text] [Related]
55. [Endoperitoneal radioisotope therapy of malignant epithelial tumors of the ovary].
Tardy A; Boidi-Trotti A
Minerva Ginecol; 1984 Apr; 36(4):199-201. PubMed ID: 6462522
[No Abstract] [Full Text] [Related]
56. Adjuvant therapy for early-stage ovarian cancer.
Berek JS
N Engl J Med; 1990 Apr; 322(15):1076-8. PubMed ID: 2181311
[No Abstract] [Full Text] [Related]
57. [A cytogenetic analysis of variants of a strain of rat ovary tumors resistant to 6-mercaptopurine and thio-TEPA].
Voitovitskii VK; Edygenova AK; Kabiev OK
Vopr Onkol; 1970 May; 16(5):87-92. PubMed ID: 4988932
[No Abstract] [Full Text] [Related]
58. Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications.
McGowan L
Clin Nucl Med; 1994 Aug; 19(8):696-8. PubMed ID: 7955749
[TBL] [Abstract][Full Text] [Related]
59. [Ovarian tumors in publications in the USSR during 1970-1972].
Livshits MA
Vopr Onkol; 1975; 21(3):104-14. PubMed ID: 805498
[No Abstract] [Full Text] [Related]
60. [The use of Thio-TEPA in patients with malignant diseases of the ovary].
Kuz'mina NA
Akush Ginekol (Mosk); 1966 Apr; 42(4):10-3. PubMed ID: 4965157
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
